Clinical Trial Update: Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating low-dose sirolimus for Kaposiform Hemangioendothelioma and related hemangiomas completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemangioma
• Kaposiform Hemangioendothelioma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Hemangioma, Kaposiform Hemangioendothelioma | Phase 4 | Status: COMPLETED